Profil
Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd. and the Chief Business Officer at Autifony Therapeutics Ltd. She holds a doctorate degree from the University of Oxford.
Postes actifs de Barbara Domayne Hayman
| Sociétés | Poste | Début |
|---|---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Membre du Comité d'Investissement | - |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Corporate Officer/Principal | - |
Formation de Barbara Domayne Hayman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Finance |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Health Technology |
















